MedPath

Efficacy of oral Ninjin'yoeito for improvement of fatigability and nutritional status in the perioperative period of primary lung cancer

Not Applicable
Conditions
ung cancer
Registration Number
JPRN-UMIN000042853
Lead Sponsor
Tokyo Medical and Dental University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1. The patient does not give consent to participate in the study. 2.The patient has a history of allergy to Ninjin'yoeito or its components. 3. The patient has severe anorexia, nausea, or vomiting, which is a cautious administration of the study drug. 4. The patient with severe hepatic or renal dysfunction.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Chalder Fatigue Scale before administration of Ninjin'yoeito, a month after surgery, and 6 months after surgery.
Secondary Outcome Measures
NameTimeMethod
Cancer Fatigue Scale, Kihon Checklist (KCL), and Controlling nutrition status (COUNT)and Prognostic nutritional index(PNI) before administration of Ninjin'yoeito, a month after surgery, and 6 months after surgery.
© Copyright 2025. All Rights Reserved by MedPath